气管切开减少持续镇痛与镇静需求
该研究为单中心、I级创伤中心2013年1月至2018年6月的回顾性综述,纳入468例气管切开患者(平均年龄58.8±18.3岁)。研究比较气管切开前72小时至后72小时的GCS、RASS、CAM-ICU评分及每日镇静、抗焦虑、镇痛药物总剂量,并用混合效应模型评估药物剂量随时间(小时)的变化。结果显示,气管切开前24小时至后24小时,丙泊酚与芬太尼的剂量及接受持续静脉给药的患者数均显著下降,总吗啡毫克当量与持续咪达唑仑亦显著下降;间歇肠内喹硫平与美沙酮给药增加。RASS、GCS、CAM-ICU评分在气管切开后早至24小时即显著改善。作者认为气管切开后镇静可转向间歇肠内给药,可能有助于观察到的术后精神状态与躁动改善。
要点
- 气管切开前24小时至后24小时,丙泊酚与芬太尼的剂量及持续静脉给药患者数均显著下降。
- 同期总吗啡毫克当量(MME)与持续咪达唑仑显著下降,间歇肠内喹硫平与美沙酮给药增加。
- 气管切开后早至24小时,RASS、GCS、CAM-ICU评分即显著改善。
- 气管切开前,<65岁患者与男性患者的总MME用量显著高于各自对照(女性),内科ICU患者显著高于外科ICU患者。
- 证据为单中心回顾性研究,证据等级:治疗/照护管理,Level III。
适用人群与场景
- 单中心I级创伤中心2013年1月至2018年6月行气管切开的468例危重外科患者,平均年龄58.8±18.3岁。
- 研究评估气管切开前72小时至后72小时的镇静、抗焦虑、镇痛用药与GCS、RASS、CAM-ICU评分。
处置流程与药物剂量
- 记录每日镇静、抗焦虑、镇痛药物总剂量,并用混合效应模型评估药物剂量随时间(小时)的变化。
- 观察到气管切开后镇静可转向间歇肠内药物(喹硫平、美沙酮给药增加),作者认为这可能有助于术后精神状态与躁动的改善。
研究设计与关键结果
- 回顾性综述,468例,单中心I级创伤中心,2013年1月至2018年6月,平均年龄58.8±18.3岁。
- 气管切开前24小时至后24小时,丙泊酚与芬太尼的剂量和持续静脉给药患者数均显著下降。
- 同期总吗啡毫克当量(MME)与持续咪达唑仑显著下降;间歇肠内喹硫平与美沙酮给药增加。
- RASS、GCS、CAM-ICU评分在气管切开后早至24小时即显著改善。
- 气管切开前总MME用量在<65岁患者和男性患者中显著升高(与女性相比);内科ICU患者显著高于外科ICU患者。
证据类型、等级与局限
- 证据类型:单中心回顾性综述;证据等级:治疗/照护管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,气管切开后镇静可转向间歇肠内药物,这可能有助于观察到的术后精神状态与躁动改善。
- 本研究提示气管切开后可持续静脉镇静与镇痛可快速减少,但为单中心回顾性研究(Level III),原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The goals of sedation in the critically ill surgical patient are to minimize pain, anxiety, and agitation without hindering cardiopulmonary function. One potential benefit of tracheostomy during endotracheal intubation is the reduction of sedation and analgesia; however, there are little data to support this supposition. We hypothesized that patients undergoing tracheostomy would have a rapid reduction in sedation and analgesia following tracheostomy.
METHODS: A retrospective review of tracheostomies performed at a single Level I trauma center from January 2013 to June 2018 was completed. An evaluation of Glasgow Coma Scale, Richmond Agitation-Sedation Scale, and Confusion Assessment Method for the intensive care unit 72 hours pretracheostomy to 72 hours posttracheostomy was performed. The total daily dose of sedation, anxiolytic, and analgesic medications administered were recorded. Mixed-effects models were used to evaluate longitudinal drug does over time (hours).
RESULTS: Four hundred sixty-eight patients included for analysis with a mean age of 58.8 ± 18.3 years. There was a significant decrease in propofol and fentanyl utilization from 24 hours pretracheostomy to 24 hours posttracheostomy in both dose and number of patients receiving these continuous intravenous medications. Similarly, total morphine milligram equivalents (MME) use and continuous midazolam significantly decreased from 24 hours pretracheostomy to 24 hours posttracheostomy. By contrast, intermittent enteral quetiapine and methadone administration increased after tracheostomy. Importantly, Richmond Agitation-Sedation Scale, Glasgow Coma Scale, and Confusion Assessment Method scoring were also significantly improved as early as 24 hours posttracheostomy. Total MME use was significantly elevated in patients younger than 65 years and in male patients pretracheostomy compared with female patients. Patients admitted to the medical intensive care unit had significantly higher MME use compared with those in the surgical intensive care unit pretracheostomy.
CONCLUSION: Tracheostomy allows for a rapid and significant reduction in intravenous sedation and analgesia medication utilization. Posttracheostomy sedation can transition to intermittent enteral medications, potentially contributing to the observed improvements in postoperative mental status and agitation.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Wallen TE, Elson NC, Singer KE, et al. Tracheostomy decreases continuous analgesia and sedation requirements. J Trauma Acute Care Surg. 2022. PMID: 35545799. doi:10.1097/TA.0000000000003673
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。